Latest News

Date Title Topic
22 May 2017 EMA Adopts a New Indication for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
19 May 2017 FDA Grants Approval to Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
18 May 2017 EMA Launches Public Consultations to Revise Three Scientific Guidelines Bioethics, legal and economic issues
17 May 2017 NaviCam for Diagnosing Gastrointestinal Tract Conditions Diagnosis, Imaging and Staging
16 May 2017 ESMO - EIU Report on Shortages of Inexpensive, Essential Cancer Medicines Bioethics, legal and economic issues
16 May 2017 Severe Skin Reactions from Pembrolizumab Palliative and supportive care - Cancer Immunology and Immunotherapy
15 May 2017 FDA Approves Ribociclib-Letrozole Co-Pack for Initial Treatment of HR-positive/HER2-negative Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
12 May 2017 FDA Approves Pembrolizumab as First-Line Combination Therapy with Pemetrexed and Carboplatin for Metastatic Non-squamous NSCLC Irrespective of PD-L1 Expression Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
Registration
11 May 2017 NICE Issues Technology Appraisal Guidance for Pegylated Liposomal Irinotecan Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2017 ESMO 2017 Young Oncologists Track – our biggest track to date!
10 May 2017 FDA Grants Accelerated Approval to Avelumab for Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
09 May 2017 Patient Guide in Glioma Now Available Also in Spanish
04 May 2017 ELCC 2017 News: Prospective Study Shows Good Concordance of EGFR Mutation Detection Between ctDNA and Tumour Samples Lung and other thoracic tumours
06 May 2017 ELCC 2017 News: Ensartinib Demonstrates CNS Activity in ALK-positive NSCLC Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy